His Internal medicine study frequently intersects with other fields, such as Immunohistochemistry. The study of Immunohistochemistry is intertwined with the study of Internal medicine in a number of ways. In his articles, Thomas M. Gress combines various disciplines, including Cancer and Cancer cell. Thomas M. Gress performs multidisciplinary studies into Pancreatic cancer and Pancreatitis in his work. Thomas M. Gress conducts interdisciplinary study in the fields of Pancreatitis and Pancreatic cancer through his research. With his scientific publications, his incorporates both Gene and Gene expression. He frequently studies issues relating to Cell culture and Genetics. He conducts interdisciplinary study in the fields of Cell culture and Gene through his research. Borrowing concepts from Receptor, he weaves in ideas under Biochemistry.
In general Signal transduction study, his work on Cell biology often relates to the realm of Cancer research, thereby connecting several areas of interest. His Cell biology study frequently draws connections between related disciplines such as Signal transduction. Thomas M. Gress integrates several fields in his works, including Cancer research and Genetics. His study connects Cell culture and Genetics. Among his Internal medicine studies, there is a synthesis of other scientific areas such as Pathology, Gastroenterology, Oncology and Endocrinology. He integrates Pathology and Cancer in his studies. In his research, Thomas M. Gress performs multidisciplinary study on Oncology and Cancer. Thomas M. Gress combines Endocrinology and Internal medicine in his research. He integrates Pancreatic cancer and Pancreas in his studies.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke;Carmen Schade-Brittinger;Klaus-Jochen Klose;Peter Barth.
Journal of Clinical Oncology (2009)
International network of cancer genome projects
Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
Stromal biology and therapy in pancreatic cancer
Albrecht Neesse;Patrick Michl;Kristopher K Frese;Christine Feig.
European evidence-based guidelines on pancreatic cystic neoplasms
Marco Del Chiaro;Marc G. Besselink;Lianne Scholten;Marco J. Bruno.
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis
Phil A. Hart;Terumi Kamisawa;William R. Brugge;Jae Bock Chung.
Transforming Growth Factor β1 Treatment Leads to an Epithelial-Mesenchymal Transdifferentiation of Pancreatic Cancer Cells Requiring Extracellular Signal-regulated Kinase 2 Activation
Volker Ellenrieder;Sandra F. Hendler;Wolfgang Boeck;Thomas Seufferlein.
Cancer Research (2001)
Stromal biology and therapy in pancreatic cancer: a changing paradigm
Albrecht Neesse;Hana Algül;David A Tuveson;Thomas M Gress.
Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis.
Jonas Rosendahl;Heiko Witt;Richárd Szmola;Eesh Bhatia.
Nature Genetics (2008)
Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.
Patrick S. Moore;Bence Sipos;Simonetta Orlandini;Claudio Sorio.
Virchows Archiv (2001)
ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas
Ulrich-Frank Pape;Aurel Perren;Bruno Niederle;David Gross.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: